Week 375 Review - Another flat week but bad enough to drop to new record low

Many shares dropped this week, but the losses were limited to £214, making it a flat week. The problem is that the losses were more than the gains from last week, so taking the deficit between cost and value to a record high of £108,617 and dropping portfolio value to £71,555 despite my monthly £130 savings going in.

The biggest loser was NUM:Numis Corp which dropped 12% to go 19% down. So much for my new rule that I sell anything that goes 15% down. The shocking state of the market at the moment makes me unwilling to sell anything, as it's not a problem with the company but rather the massive volatility in the market as the British economy is systematically destroyed from within.

AJB:AJ Bell dropped 5% after last week's 10% rise, so is now 10% down

CEY:Centamin also dropped 5% despite great news on the near completion of their solar power plant.

SBTX:SkinBioTherapeutics wins Share of the Week as it almost halved the losses I would have shown without it, and it was the only one to climb by 5%.

It's been flat throughout one of the most turbulent periods in decades.

Appropriate to see that the trend line has gone below the chart line, rather than the chart line going above the trend line.

Here's the ISA and shares portfolio after week 11 of year 8.

			Weekly Change
Cash	£56.42		-£3.75
Portfolio cost	£82,003.25		+£0
Portfolio sell value (bid price-commission)	£29,775.24	(-63.7%)	+£82.75
Potential profits	£471.51		+£0
Yr 8 Dividends	£0		+£0
Yr 8 Interest	£0.02		+£0
Yr 8 Profit from sales	-£995.63		+£0
Yr 8 projected avg monthly profit	-£395.16	(-10.7%)	+£39.52
Total Dividends	£11,768.92		+£0
Total Interest	£0.02		+£0
Total Profit from sales	£27,098.43		+£0
Average monthly cash profit	£445.27	(12.0%)	-£1.19
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	87%		+0%

Cash was down due to fees, and amazingly this portfolio was slightly up by £82. Long term performance still above target thanks to PBX:Probiotix dividend, but imminent demise of DDDD:4D Pharma will negate that. Nice to know that it's inevitably going to get much worse than it is even now.

Very flat

Same story as the combined chart, with trend line crossing below the chart line

The SIPP looks like this after week 359 overall and week 47 of year 7.

			Weekly Change
Cash	£57.31		-£19.85
Portfolio cost	£96,320.45		+£123.90
Portfolio sell value (bid price - commission)	£41,121.23	(-57.3%)	-£296.82
Potential profits	£568.00		-£17.01
Yr 7 Dividends	£10,772.53		+£0
Yr 7 Interest	£0.01		+£0
Yr 7 Profit from sales	-£3,290.88		+£0
Yr 7 projected avg monthly profit	£674.77	(14.2%)	-£14.66
Total Dividends	£13,976.92		+£0
Total Interest	£0.21		+£0
Total Profit from sales	£20,433.75		+£0
Average monthly cash profit	£403.47	(8.5%)	-£1.12
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	59%		+0%

Cash dropped £19 thanks to monthly charges plus a few AJ Bell account charges I'd forgotten to subtract over the last few months. Portfolio cost went up £123 as I bought 54 shares in EMG:Man Group at 226.651p, but portfolio value dropped £286 thanks to most of my magic formula shares falling. Potential profits only slipped £17 thanks to a small drop in PLUS:Plus500.

Ditto the charts above

Also ditto the charts above

The trading account looks like this after week 325 overall and week 13 of year 7.

			Weekly Change
Cash	£0.10		+£0
Portfolio cost	£1,849.21		+£0
Portfolio sell value (bid price - commission)	£658.85	(-64.4%)	+£0
Potential profits	£0.00		+£0
Year 7 Dividends	£0.00		+£0
Year 7 Interests	£0.01		+£0
Year 7 Profit	-£71.73		+£0
Yr 7 projected avg monthly profit	-£23.91	(-15.5%)	+£1.99
Dividends	£60.10		+£0
Interest	£0.01		+£0
Profit from sales	£154.87		+£0
Average monthly cash profit	£2.87	(1.9%)	-£0.01
(Sold stocks profit + Dividends - Fees / Months)

Absolutely nothing changed

The trend line it pointing upwards!!

I despair of ever again getting that feeling of great joy when brilliant news lands and a share price rockets. For over a year the news has either been dire or any good news has done nothing for the share price. I'm completely fed up, and way worse off than I would have been putting my money under the mattress. It's a good job I enjoy documenting the numbers, as this whole exercise has been 7 years of wasted time so far.